Please assess the completion status of the following clinical trial:

Trial Title: Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Be a hospitalized male or female subject between birth (\> 37 weeks gestational age) and \< six (6) months of age.~* Have a clinical indication of pain or fever.~* Have written informed consent provided by legal parent, guardian, or authorized agent prior to participation in the study or performance of any study-only related procedures.~Exclusion Criteria:~* Have inadequate intravenous access.~* Have an uncorrected ductus dependent congenital heart disease.~* Have any history of allergy or hypersensitivity to non-steroidal anti-inflammatory drug or aspirin.~* Have a current history of uncorrected hypovolemia or acute renal disease.~* Have a current history of acute liver disease.~* Have received NSAID, acetaminophen, or aspirin drug therapy within four hours prior to dosing. Have received another investigational drug within the past 30 days.~* Be otherwise unsuitable for the study, in the opinion of the Investigator.

- Gender: ALL
- Minimum Age: None
- Maximum Age: 6 Months
- Healthy Volunteers: f

Study Arms:
- Ibuprofen (Type: EXPERIMENTAL): Ibuprofen, 10 mg/kg

Based on this trial design, predict the completion outcome and termination type (if applicable).